Daratumumab Passes Key Hurdle to First Approved Treatment for Smoldering Myeloma

(MedPage Today) — A potential first-ever FDA-approved treatment for smoldering myeloma received a positive review from an advisory committee, but not without reservations, even from panelists who voted in favor.
By a 6-2 vote, the Oncologic Drugs…